Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mross

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Onkologie|July 7, 2001
[Clinical trials: prerequisite of evidence-based oncology: reality, perspectives and a new tool recruited--the Internet]K Mross, W März
Praxis|April 28, 2001
[Chemotherapy of colonic carcinoma in the year 2001]K Mross, D Semsek
Anticancer Research|March 1, 1986
The clinical significance of tissue polypeptide antigen in breast cancer patientsK Mross, G Bandlow
Praxis|October 22, 2004
[Adjuvant and palliative anticancer treatment of colon carcinoma in 2004]M Medinger, S Steinbild, K Mross
Onkologie|April 1, 1985
[Tissue polypeptide antigen (TPA) and plasma TPA levels during the postoperative course in female primary breast carcinoma patients. 1st results of a long-term study]K Mross, I Wolfrum, H Rauschecker
Deutsche Medizinische Wochenschrift (1946)|March 25, 1977
[Immunodiagnosis of malignant disease. I. The electrophoresis-mobility test in the diagnosis of bronchial carcinoma (author's transl)]F R Douwes, U Hüttemann, K Mross
Journal of Chromatography|October 29, 1993
Determination of the new podophyllotoxin derivative NK 611 in plasma by high-performance liquid chromatography with ultraviolet detectionA Hüttmann, K Mross, D K Hossfeld
Cancer Chemotherapy and Pharmacology|January 1, 1993
Effects of verapamil on the pharmacokinetics and metabolism of epirubicinK Mross, K Hamm, D K Hossfeld
Oncology|January 1, 1977
Immunodiagnostics of malignant diseases. II. The electrophoretic mobility test in the diagnosis of gynecological malignanciesF R Douwes, W Hoffmann, K Mross
Onkologie|June 1, 1982
[Leukocyte migration inhibition test using myelin basic protein in patients with malignant diseases]K Mross, B Mross, D I Wolfrum
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Onkologie|July 7, 2001
[Clinical trials: prerequisite of evidence-based oncology: reality, perspectives and a new tool recruited--the Internet]K Mross, W März
Praxis|April 28, 2001
[Chemotherapy of colonic carcinoma in the year 2001]K Mross, D Semsek
Anticancer Research|March 1, 1986
The clinical significance of tissue polypeptide antigen in breast cancer patientsK Mross, G Bandlow
Praxis|October 22, 2004
[Adjuvant and palliative anticancer treatment of colon carcinoma in 2004]M Medinger, S Steinbild, K Mross
Onkologie|April 1, 1985
[Tissue polypeptide antigen (TPA) and plasma TPA levels during the postoperative course in female primary breast carcinoma patients. 1st results of a long-term study]K Mross, I Wolfrum, H Rauschecker
Deutsche Medizinische Wochenschrift (1946)|March 25, 1977
[Immunodiagnosis of malignant disease. I. The electrophoresis-mobility test in the diagnosis of bronchial carcinoma (author's transl)]F R Douwes, U Hüttemann, K Mross
Journal of Chromatography|October 29, 1993
Determination of the new podophyllotoxin derivative NK 611 in plasma by high-performance liquid chromatography with ultraviolet detectionA Hüttmann, K Mross, D K Hossfeld
Cancer Chemotherapy and Pharmacology|January 1, 1993
Effects of verapamil on the pharmacokinetics and metabolism of epirubicinK Mross, K Hamm, D K Hossfeld
Oncology|January 1, 1977
Immunodiagnostics of malignant diseases. II. The electrophoretic mobility test in the diagnosis of gynecological malignanciesF R Douwes, W Hoffmann, K Mross
Onkologie|June 1, 1982
[Leukocyte migration inhibition test using myelin basic protein in patients with malignant diseases]K Mross, B Mross, D I Wolfrum
Pageof 7